Loxoprofen sodium (Standard)
Loxoprofen (sodium) (Standard) is the analytical standard of Loxoprofen (sodium). This product is intended for research and analytical applications. Loxoprofen sodium is a non-steroidal, orally active anti-inflammatory agent with analgesic and anti-pyretic properties. Loxoprofen sodium is a nonselective COX inhibitor with IC50s of 6.5 and 13.5 μM for COX-1 and COX-2, respectively. Loxoprofen sodium can reduce atherosclerosis and shows antitumor activity.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- Reinheit : 98%
- CAS. Nr.: 80382-23-6
- Formel: C15H17NaO3
- Molecular Weight:268.28
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Product Information
-
Chemical Information
- Reinheit & Dokumentation
-
Help & FAQs
-
HY-B0578A
Loxoprofen sodiumAnti-Inflammatory Agent -
HY-B0440
TenoxicamCOX Inhibitor -
HY-13568
BenoxaprofenNonsteroidal Anti-inflammatory Agent -
HY-B0386
Flunixin meglumineCOX Inhibitor -
HY-118078
RobenacoxibCOX-2 Inhibitor -
HY-105028
Tenidap5-LOX/COX Inhibitor -
HY-112731
TFAPCOX-1 Inhibitor -
HY-100516
CimicoxibCOX-2 Inhibitor -
HY-B0386R
Flunixin meglumine (Standard)COX Inhibitor -
HY-B0440R
Tenoxicam (Standard)COX Inhibitor -
HY-118078R
Robenacoxib (Standard)COX-2 Inhibitor -
HY-100516R
Cimicoxib (Standard)COX-2 Inhibitor
Product Information
Information
Anwendung
The compound is the grade of analytical standard, which is the reference standard supplied assay. It is commonly used in qualitative, quantitative and methodological research experiments in HPLC, GC and MS.
Chemical Information
-
CAS. Nr. 80382-23-6
-
Molecular Weight 268.28
-
Formel C15H17NaO3
-
SMILES
O=C1C(CCC1)CC2=CC=C(C(C)C(O[Na])=O)C=C2
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Reinheit & Dokumentation
Verweise
[1]. Riendeau D, et al. Evaluation of loxoprofen and its alcohol metabolites for potency and selectivity of inhibition of cyclooxygenase-2. Bioorg Med Chem Lett. 2004;14(5):1201-1203. [Content Brief]
[2]. Paudel S, et al. Assessing Drug Interaction and Pharmacokinetics of Loxoprofen in Mice Treated with CYP3A Modulators. Pharmaceutics. 2019;11(9):479. Published 2019 Sep 16. [Content Brief]
[3]. Hamaguchi M, et al. Loxoprofen Sodium, a Non-Selective NSAID, Reduces Atherosclerosis in Mice by Reducing Inflammation. J Clin Biochem Nutr. 2010 Sep;47(2):138-47. [Content Brief]
[4]. Kanda A, et al. Loxoprofen sodium suppresses mouse tumor growth by inhibiting vascular endothelial growth factor. Acta Oncol. 2003;42(1):62-70. [Content Brief]
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)
Loxoprofen sodium (Standard) Related Classifications
HY-B0578AR Related Classifications
Powered by Bioz